Biotech Stocks
Below are all our articles under the above category.
Monash IVF (ASX:MVF): Just when you thought a difficult 5 year span was over…
In the decade since fertility provider Monash IVF (ASX:MVF) listed, it was not an easy journey. Only a few months…
EBR Systems (ASX:EBR): Another heart-focused medtech that has gained FDA approval
Mere days after Artrya (ASX:AYA) obtained FDA approval for its heart-health technology, EBR Systems (ASX:EBR) has achieved that same feat.…
Mesoblast (ASX:MSB): Which direction will this rollercoaster of a $2bn biotech company go next?
Biotech company Mesoblast (ASX:MSB) is the ultimate definition of a rollercoaster company. As of April 7, 2025, it is capped…
Orthocell (ASX:OCC): All systems go for a US market roll out of its flagship Remplir nerve repair product
Orthocell (ASX:OCC) is the latest ASX biotech to obtain FDA approval. Its nerve repair product Remplir was already approved in…
Artrya (ASX:AYA): Newly FDA 510(k) approved, and so its all systems go!
3 and a half years after listing and nearly 7 years after its founding, Artrya (ASX:AYA) achieved the aspiration of…
Should you use your tax cut to invest in stocks? And how should you go about it?
Should you use your tax cut to invest in stocks? With another unexpected round of tax cuts starting from the…
Here are 6 stocks that got promoted in the ASX quarterly rebalance, and 6 that got demoted
On Monday March 24, the ASX quarterly rebalance will be effective. Stocks will be promoted into new indices, while others…
Truscreen (ASX:TRU): Taking a radical path to wide-spread commercialisation
Truscreen (ASX:TRU) is not taking the conventional path ASX medtech stocks take to market. Typically they seek approval in the…
Atomo Diagnostics (ASX:AT1): Not just another Rapid Diagnostic (RDT) company
Atomo Diagnostics (ASX:AT1) may be written off by some investors just because it is a rapid test kit company. Yes,…
Nanosonics (ASX:NAN): A disinfection company turning itself around and has gained 50% so far in 2025
Nanosonics (ASX:NAN) was in the best space to be during the pandemic – disinfection technology. Its flagship Trophon machines are…
Will the RBA cut rates in February? 3 reasons why they might and 3 reasons why they might not!
Will the RBA cut rates in February? That’s the question on everyone’s minds. The board will hold its first meeting…
Avita Medical (ASX:AVH): Will the FDA’s last minute Christmas present catapult it to new heights in 2025?
Avita Medical (ASX:AVH) received not one, but two Christmas presents from the FDA. On December 19, it announced 510(k) clearance…
Here are our 6 Best ASX Stocks for 2025 and why you should give them a look!
Here are our 6 Best ASX Stocks for 2025! Opthea (ASX:OPT) Its been a long wait, but 2025 will…
5 Promising Stocks Fighting Alzheimers to Watch Now
Let’s take a look at the most promising stocks fighting Alzheimers disease. Alzheimer’s disease is one of the most daunting…